Log in
Email Address
Password
Forgot your password?
Not Registered?

Featured Tenants

 kromeknew


Kromek is pioneering digital colour imaging for x-rays and has brought ground-breaking innovation to materials technology and advanced 3D imaging, that will literally change the way in which we see the world.

Click here to learn more about Kromek

Featured Opportunity
Provision of market research response service to members of NETPark Net.

The aim of this contract is to give clients of NETPark access to a rapid response market intelligence service: swift and accurate market research which will help them identify partners, suppliers, customers and competitors. Download the documentation, which includes the specification.


For further information click here

Polls



CDEP logo

cddc   European Union emblem

Microneedles give hope to millions
Bookmark and Share Add This     Email notification Email a Friend    print Printable version

Microneedles give hope to millions

2008-06-30
Newsfeed

A new technique which uses microscopic needles to deliver drugs to the eyes could offer hope to millions of patients suffering from eye diseases that can potentially lead to loss of vision.


A new technique which uses microscopic needles to deliver drugs to the eyes could offer hope to millions of patients suffering from eye diseases that can potentially lead to loss of vision.

Researchers at the Georgia Institute of Technology and Emory University in America looked at how microneedles can be used to deliver drugs to the eye through a minimally invasive procedure. The needles do not penetrate as far as traditional needles, meaning they are far less likely to cause damage.

The technique could revolutionise the treatment of common eye conditions such as glaucoma, macular degeneration and diabetic retinopathy.

"The eyes are one of the most sensitive and delicate organs in the human body, and perhaps the most fascinating," said researcher Samirkumar Patel. "Although the research is at an early stage it does show that it is possible to use microneedles to effectively deliver drugs to targeted sections of the eye.

"No inflammatory response or other adverse effects were observed in our early tests. This is promising news for those who are suffering from vision threatening diseases such as glaucoma, macular degeneration and diabetic retinopathy."

The research team's findings were presented to international experts at the Ophthalmic Drug Delivery symposium held at the Royal Pharmaceutical Society of Great Britain.

Copyright © The Press Association 2008